JAMA pediatrics

Weight-Loss Medicines and Lifestyle Changes for Treating Childhood Obesity: A Review and Comparison

Updated

Abstract

A total of 42 randomized clinical trials with 3835 participants were analyzed.

  • Treatments that combined pharmacotherapy and lifestyle treatment showed the greatest effectiveness in reducing body mass index (BMI) and related measures.
  • Semaglutide plus counseling was linked to a significant BMI reduction of -8.31.
  • All pharmacological treatments yielded better results when combined with lifestyle treatment compared to medications alone.
  • HBLT as a standalone treatment resulted in a notable decrease in BMI of -3.85.
  • Combining lifestyle treatment with obesity management medications was associated with the most significant short-term weight reduction in adolescents.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Conflict of Interest Disclosures: Dr Torbahn reported having a board membership of the Working Group Obesity in Childhood and Adolescence of the German Association for the Study of Obesity; being a co-opted board member of the European Childhood Obesity Group; and receiving travel grants or reimbursements from the European Association for the Study of Obesity, the German Association for the Study of Obesity, and the European Childhood Obesity Group outside the submitted work. Dr Weghuber reported receiving consulting fees from Novo Nordisk, Eli Lilly, and Rhythm Pharmaceuticals outside the submitted work. No other disclosures were reported.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free